Phase I pharmacokinetic and pharmacodynamic evaluation of the vascular disrupting agent OXi4503 in patients with advanced solid tumors.
2010 ◽
Vol 28
(15_suppl)
◽
pp. 2594-2594
◽
Keyword(s):
Phase I
◽
2012 ◽
Vol 18
(5)
◽
pp. 1415-1425
◽